Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

LAS VEGAS — Max Verstappen won the Las Vegas Grand Prix on Saturday night after capturing the lead from championship leader Lando Norris at the start and never looking back. The Formula 1 cars blasted ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

How does F1 qualifying work? Here’s everything you need to know about the knockout format, pole position, new rules for 2022 and more. Formula 1 races may be on Sundays but all racing fans know that ...

Capable of rapid speeds, the fastest Formula E car in the ABB FIA Formula E World Championship’s history has been engineered for the pioneers of today and next-generation talent of tomorrow, setting a ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

In recent developments, Recursion Pharmaceuticals unveiled advances in its AI platform for drug discovery, forming collaborations with major pharmaceutical groups including Sanofi, Roche/Genentech, ...

Red Bull star Max Verstappen won his fourth Formula 1 United States Grand Prix in five years, Sunday, Oct. 19 at the Circuit of the Americas in Austin, Texas. Verstappen started on pole and lead ...